Business Development Life Sciences

Robert L. Bencher, MBA

*** ***** ******** ******, **** 3C

Newtown, PA 18940

Ph: 215-***-****

*************@*****.***

https://www.linkedin.com/in/robert-bencher-01069a3

TRANSFORMATIONAL SEASONED LIFE SCIENCE DIRECTOR

Bringing extensive experience and deep market knowledge to help solve today’s challenges

Results-focused business development executive with experience in early-stage, mid-level, and large company environments. Skilled in developing, curating, and maintaining collaborative relationships with strategic clients.

LIFE SCIENCES / CLINICAL DIAGNOSTICS / DRUG DEVELOPMENT / CLINICAL TRIALS

CONTRACT RESEARCH ORGANIZATION / BUSINESS DEVELOPMENT / GOVERNANCE

ASSAY DEVELOPMENT / CONTRACT MANUFACTURING / ADVISOR / MENTORING

PROFESSIONAL EXPERIENCE

2006 — Present Rules Based Medicine, Inc. – A Q Squared Solutions Company

Director of Business Development, USA, Canada, & China

Philadelphia, Pennsylvania

Direct the early-stage development, positioning, and strategy of a highly successful contract business.

Have increased RBM’s contract research organization business by over 200%.

Direct the procurement of substantial numbers of multi-year agreements to identify biomarkers that support clinical trials.

Manage large pharmaceutical outsourcing projects and client relationships.

Deliver technical guidance and support for collaborations with academic, governmental, and industrial clients.

Have learned to work with a number of CRM based software packages.

2004 — 2005 MetriGenix US, Inc.

Director of Business Development, USA and Europe

Manager of Business Development, USA

Philadelphia, Pennsylvania

Fostered good relationships with pharmaceutical, biotech, and academic accounts.

Developed third-party lease and acquisition plans for capital equipment.

Presented technical seminars at several client sites and scientific conferences.

Negotiated CRO collaborations for gene expression services in the metabolic and cardiac disease areas.

Established the commercial microarray business for genotyping Influenza Virus within the public health sector.

1998 — 2003 Bayer Health Care, LLC — Drug Discovery Business Group

(The Drug Discovery Business Group was acquired from Chiron Corporation.)

Worldwide Business Manager — Global Sales and Marketing, QuantiGene Technologies

Philadelphia, Pennsylvania

Developed a business partnership focused on the life sciences with a biotechnology company.

Helped execute new business strategies for the emerging Genomics market.

Established pharmaceutical client base in the USA, Europe, and Japan.

Negotiated technology transfer and licensing agreements for gene expression.

Obtained several significant commercial contracts valued in excess of $5M.

1995 — 1998 Pall Life Sciences — Microfiltration and Ultrafiltration Products

Area Manager — Midwest

Detroit, Michigan

Helped strengthen a highly cross-functional organizational matrix.

Planned and coordinated sales and marketing activities for healthcare/OEM and membrane products.

Implemented tactical sales plans through both direct and distributor sales activities.

Developed and applied processes for assessing new markets, products, and channels.

Was formally recognized for new sales growth in FY97 and finished 102.4% to plan in FY96.

1987 — 1995 Johnson & Johnson — Ortho Clinical Diagnostics

Distributor Sales Executive

Laboratory Sales Representative

Immunodiagnostic Sales Representative

Boston, Massachusetts / Charlotte, North Carolina

Successfully negotiated a large number of contracts for national accounts.

Developed and carried out territory operation plans to maximize customer contact.

Prepared distributor marketing plans, cost proposals, and forecast packages.

Was named to the President’s Club, the 100% Club, and the Winner’s Circle, partly in recognition of on-going contributions to the technical development of colleagues.

1983 — 1987 Abbott Diagnostics — Hepatitis & HIV Business Unit

Research Associate, Chemist

North Chicago, Illinois

Developed chemical reagents for the automated ELISA project, which led to the first commercially available HIV blood test.

Worked closely with the manufacturing and marketing functions as well as with software engineers, independent contractors, and consultants to bring new products to market efficiently and successfully.

Helped design many protocols, experiments, and FDA immunoassay submission packages.

Other Work

Experience Adjunct Instructor in Business, Economics, and Finance at Delaware Valley University, Doylestown, PA (2020-present), Gwynedd-Mercy University, Philadelphia, PA (2013-2015), Alvernia University, Philadelphia, PA (2015-2017), and Central Piedmont Community College, Charlotte, NC (1988-1993)

Served as Consultant and member of Scientific Advisory Board for an early-stage adipocyte biology company.

Education Michigan State University

Bachelor of Arts in Natural Science — Chemistry, 1983

Loyola University of Chicago

Master of Business Administration — Marketing and Finance, 1987

Completed course in Marketing Strategy at The Wharton School, The University of Pennsylvania, Philadelphia, Pennsylvania, 2000.

Completed course in Finance at The Mendoza College of Business, The University of Notre Dame, Notre Dame, Indiana, 2002.

Presentations Cambridge Healthtech Institute

Presented a poster at 5th Annual Microarrays in Medicine, Arrays of Possibilities Conference, April 2004, Boston, Massachusetts

R. L. Bencher and E. Eastman: An innovative strategy and streamlined platform in identifying biological markers for cancer detection.

Keystone Symposia

Presented a poster at the Chronic Diseases Symposium, January 2005, Keystone, Colorado

R. L. Bencher and B. M. Buehrer: Differential gene expression of human metabolic tissues using a l0w-density metabolic DNA microarray chip.

Clearwater Conference

Presented a poster at the 21st Clinical Virology Conference, May 2005, Clearwater, Florida

R. L. Bencher and P. A. Clark: Comparison of a respiratory virus array (BioChip) to viral culture and polymerase chain reaction (PCR).

Philip Morris International, Inc. Executive Summit

Oral Presentation at Annual Executive Symposia, May 2012, The Mandarin Hotel, Zurich, Switzerland

Determining Translational Biomarker Patterns by Multi-Analyte Profiling

Nordic Market and Patient Access Forum

Oral Presentation at Scientific Conference, March 2014, Sheraton Hotel, Stockholm, Sweden

A Survey of the Emerging Technologies Changing the Course of Patient Treatment.

Pharmacovigilance

Oral Presentation at 2nd Annual Scientific Conference, June 2016, The Strand Palace Hotel, London, England

The Utilization of Biomarkers to Ensure Safe and Effective Therapies.

Merck Technology Symposium

Presented a poster at the 17th Annual Technology Symposium, September 2018, Long Branch, New Jersey

R. L. Bencher and L. A. Brunet: The Immunomodulatory Effects of Cancer Therapy on IFN-gamma Responses in the Periphery.

IPF Conference

Presented a poster at the 7th Annual Idiopathic Pulmonary Fibrosis Summit, September 2023, Boston, Massachusetts

R.L. Bencher and P. Schafer: Development and Validation of 5 Idiopathic Pulmonary Fibrosis (IPF) Biomarker Panels Compromising 12 Immunoassays: Advancing Clinical Diagnostics, Pharmacodynamic, and Disease Assessments in IPF.

American Thoracic Society

Co-author of Journal Article, October 2024

R.L. Bencher and P. Schafer: Development of a Multi-biomarker Assay for Serum Proteins by the Prognostic Lung Fibrosis Consortium (PROLIFIC)

Contact this candidate